Frankfurt, Germany

Akhileswer Sinharay

This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976-1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1976-1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akhileswer Sinharay: Innovator in Antiprotozoal Compounds

Introduction

Akhileswer Sinharay is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiprotozoal compounds. With a total of 2 patents to his name, Sinharay's work focuses on creating effective solutions against various pathogens.

Latest Patents

Sinharay's latest patents include innovative compounds that target pathogens. The first patent, titled "Antiprotozoal (1-alkyl-5-nitro-imidazolyl-2-alkyl)-pyridazines," discloses new (1-alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryl compounds along with a process for their manufacture. These compounds have shown effectiveness against bacteria, protozoa, and fungi. The second patent, "Antiprotozoal (1-alkyl-5-nitro-imidazolyl-2-alkyl)-pyrimidines," similarly presents new compounds and their manufacturing process, emphasizing their potential in combating various pathogens.

Career Highlights

Akhileswer Sinharay is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on innovative research and development in the field of antiprotozoal medications.

Collaborations

Sinharay has collaborated with esteemed colleagues, including Erhardt Winkelmann and Wolfgang Raether. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Akhileswer Sinharay's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to addressing health challenges posed by pathogens. His work continues to pave the way for new treatments and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…